Bruker | BRKR - Sales Revenues

Stock Price
43.64
Daily Change
0.76 1.77%
Monthly
6.18%
Yearly
15.45%
Q2 Forecast
42.02

Bruker reported $823.4M in Sales Revenues for its fiscal quarter ending in March of 2026.





Sales Change Date
ABB USD 8.73B 322M Mar/2026
Agilent USD 1.8B 63M Dec/2025
Ametek USD 1.93B 70M Mar/2026
Bio Techne USD 311.4M 15.5M Mar/2026
Bio-Rad Laboratories USD 592.1M 101.1M Mar/2026
Bruker USD 823.4M 153.8M Mar/2026
Charles River Laboratories USD 995.8M 1.6M Mar/2026
Danaher USD 5.95B 890M Mar/2026
Fujikura JPY 327.43B 31.49B Mar/2026
Furukawa JPY 61.11B 8.77B Mar/2026
General Electric Aerospace USD 11.6B 270M Mar/2026
Hitachi JPY 3.08T 370B Mar/2026
Illumina USD 1.09B 70M Mar/2026
IQVIA Holdings USD 4.15B 210M Mar/2026
Mettler Toledo International USD 947.13M 182.87M Mar/2026
Mitsubishi Electric JPY 1.74T 320B Mar/2026
Mitsubishi Heavy Industries JPY 1.65T 440B Mar/2026
Myriad Genetics USD 200.4M 9.4M Mar/2026
Nikon Corporation JPY 193.26B 22.27B Mar/2026
Olympus JPY 295.28B 34.23B Mar/2026
Repligen USD 194M 3.91M Mar/2026
Revvity USD 711M 61.06M Mar/2026
Smiths GBP 1.44B 133M Jan/2026
Thermo Fisher Scientific USD 11.01B 1.2B Mar/2026
Waters USD 1.27B 338M Mar/2026